July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two ...
Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.
A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...
Justin Bone detailed the days leading up to his arrest, describing taking drugs and wandering various parts of the city after being dropped off by RCMP.
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...
With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...
At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...
This first-in-class differentiated approach will be highlighted during a Featured Research Session entitled Alzheimer's therapy: mechanisms beyond amyloid ...
Initially, unadjusted analyses suggested a slight increase in the risk of MCI or dementia among hypnotic users compared with ...
Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement with Decathlon Capital Partners for a significant ...
Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...
A British start-up is sending a miniature laboratory into orbit to open a new frontier in the battle against Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results